The National Human Rights Commission (NHRC) has emphasized that the manufacture, distribution, and sale of unsafe drugs and medical devices constit...
Recent studies have identified the alarmone Ap4A as a significant enhancer of aminoglycoside antibiotics' bactericidal activity. This discovery sug...
The General Pharmaceutical Council (GPhC) has issued a warning regarding emerging patient safety risks in the pharmacy sector. Concerns have been r...
Eli Lilly's oral GLP-1 therapy, orforglipron, has shown promising results in its Phase III ATTAIN-1 study, achieving a 12.4% average weight reducti...
A recent study has employed Quantitative Structure-Property Relationship (QSPR) modeling and Multi-Criteria Decision Making (MCDM) to evaluate the ...
The global human insulin market is experiencing steady growth due to the increasing prevalence of diabetes and the introduction of biosimilar insul...
A recent study has employed Quantitative Structure-Property Relationship (QSPR) modeling and Multi-Criteria Decision Making (MCDM) to evaluate anti...
As weight loss drugs such as Ozempic and Mounjaro gain popularity, concerns have emerged about their potential links to cancer. These drugs, known ...
Healthcare Improvement Scotland (HIS) has released a report indicating that only 10% of people experiencing medication side effects report them thr...
A meta-analysis published in BMC Medicine has found that patients who stop taking weight loss drugs, such as Ozempic, often experience a rebound in...